Drug use and addiction: Evolutionary perspective

Australian and New Zealand Journal of Psychiatry

Volumn 43, Issue 11, 2009, Pages 1049-1056

  Adamson, Simon ^a   Todd, Fraser ^a   Sellman, Doug ^a   Durrant, Russil ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b NONE

Author keywords

Addiction; Behavioural addictions; Drug use; Evolution; Life history theory

Indexed keywords

CLINICAL PRACTICE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG DEPENDENCE; DRUG USE; EVOLUTION; HEALTH CARE POLICY; HUMAN; LIFE HISTORY; REVIEW;

BEHAVIOR, ADDICTIVE; EMOTIONS; EVOLUTION; HUMANS; MOTIVATION; REWARD; SUBSTANCE-RELATED DISORDERS;

EID: 70449353718     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1080/00048670903270449     Document Type: Review

References (80)

1. Katz SH, Voigt MM. B read and beer: the early use of cereals in the human diet. Expedition 1998; 28:23-34.
2. Booth M. Opium: A history. London : Simon and Schuster, 1996.
3. Dobkin de Rios M. Hallucinogens: cross-cultural perspectives. Prospect Heights , IL: Waveland Press , 1990.
4. Rudgley R. The alchemy of culture: intoxicants in society. London: British Museum Press, 1993.
5. Von Bibra E. P lant intoxicants. Rochester, VT: Healing Art Press, 1855/1995.
6. Dudley R. Evolutionary origins of human alcoholism in primate frugivory. Q Rev Biol 2000; 75:3-15.
7. Dudley R. Fermenting fruit and the historical ecology of ethanol ingestion: is alcoholism in modern humans an evolutionary hangover? Addiction 2002; 97:381-388.
8. Hill EM, C how K. Life-history theory and risky drinking. Addiction 2002; 97:401-413.
9. Lende DH. Evolution and modern behavioral problems: the case of addiction. In: Trevathan WR, Smith EO, McKenna JJ, eds. Evolutionary medicine and health: new perspectives. New York: Oxford University Press, 2008:277-290.
10. Lende DH, Smith EO. Evolution meets biopsychosociality: An analysis of addictive behaviour. Addiction 2002; 97: 447-458.
11. Nesse RM. An evolutionary perspective on substance abuse. Ethol Sociobiol 1994; 15: 339-348.
12. Nesse RM, Berridge KC. Psychoactive drug use in evolutionary perspective. Science 1997; 278 (5335): 63-66.
13. Saah T. The evolutionary origins and signifi cance of drug addiction. Harm Reduct J 2005; 2: 1-7.
14. Sullivan RJ, Hagen EH. Psychotropic substance-seeking: evolutionary pathology or adaptation? Addiction 2002; 97: 389-400.
15. Adamson SJ, Todd FC, Sellman JD, Huriwai T, Porter J. Co-existing psychiatric disorders in a New Zealand outpatient alcohol and other drug clinical population. Aust N Z J Psychiatry 2006; 40: 164-170.
16. Mueser KT, Drake RE, Turner W, McGovern M. Comorbid substance use disorders and psychiatric disorders. In Miller WR, Carroll KM, eds. Rethinking substance abuse: what the science shows and what we should do about it. New York: Guildford Press, 2006:115-132.
17. Khantzian EJ. The self-medication hypothesis of substance use disorders: A reconsideration and recent applications. Harvard Rev Psychiatry 1997; 4: 231-244.
18. Turner BL, Maes K, Sweeney J, Armelagos GJ. Human evolution, diet and nutrition: when the body meets the buffet. In: Trevathan WR, Smith, EO, McKenna JJ, eds. Evolutionary medicine and health: new perspectives. New York: Oxford University Press, 2008:55-72.
19. Miller WE. Intoxicated lepidopterans: how is their fi tness affected, and why do they tipple? J Lepidopteris Soc 1997; 51: 277-287.
20. Ervin FR, Palmour RM, Young SN, Guzman-Flores C, Juarez J. Voluntary consumption of beverage alcohol by vervet monkeys: population screening, descriptive behaviour and biochemical measures. Pharmacol Biochem Behav 1990; 36: 367-373.
21. Siegal RK, Brodie M. Alcohol self-administration by elephants. Bull Psychonom Soc 1984; 22: 49-52.
22. Berridge KC, Kringelbach ML. Affective neuroscience of pleasure: reward in humans and animals. Psychopharmacology 2008; 199: 457-480.
23. Kenny PJ. Brain reward systems and compulsive drug use. Trends Pharmacol Sci 2007; 28: 135-141.
24. Pomerleau CS. Co-factors for smoking anDevolutionary psychobiology. Addiction 1997 ; 92: 397-408.
25. Kelley AE, Berridge KC. The neuroscience of natural rewards: relevance to addictive drugs. J Neurosci 2002; 22: 3306-3311.
26. Nestler EJ. Is there a common molecular pathway for addiction? Nat Neurosci 2005; 8: 1445-1449.
27. Picciotto MR. Common aspects of the action of nicotine and other drugs of abuse. Drug Alcohol Depend 1998; 51: 165-172.
28. Koob GF, Le Moal M. Addiction and the brain antireward system. Annu Rev Psychol 2008; 59: 29-53.
29. Wise RA. Drug activation on brain reward pathways. D rug Alcohol Depend 1998; 51: 13-22.
30. Glocker ML, Langleben DD, Ruparel K et al.. Baby schema modulates brain reward system in nulliparous women. Proc Natl Acad Sci 2009; 106: 9115-9119.
31. Panksepp J, Knutson B, Burgdorf J. The role of brain emotional systems in addictions: A neuro-evolutionary perspective and new 'self-report' animal model. Addiction 2002; 97: 459-469.
32. Phillips AG, Blaha CD, Pfaus JG, Blackburn JR. Neurobiological correlates of positive emotional states: dopamine, anticipation and reward. In: Strongman KT, ed. International review of emotion, vol.2. London: John Wiley and Sons, 1992:31-49.
33. Moos RH. Social contexts and substance use. In: Miller WR, Carroll KM, eds. Rethinking substance abuse: what the science shows and what we should do about it. New York: Guildford Press, 2006:182-200.
34. Durrant R, Thakker J. Substance use and abuse: cultural and historical perspectives. Thousand Oaks: Sage Publications, 2003.
35. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edn, text revision. Washington, DC: American Psychiatric Association, 2000.
36. Kelley AE. Memory and addiction: shared neural circuitry and molecular mechanisms. Neuron 2004; 44: 161-179.
37. Alcaro A, Huber R, Panksepp J. Behavioral functions of the mesolimbic dopaminergic system: An affective neuroethological perspective. Brain Res Rev 2007; 56: 283-321.
38. Robinson TE, Berridge KC. Addiction. A nnu Rev Psychol 2003; 54: 25-53.
39. Cardinal RN, Everitt BJ. Neural and psychological mechanisms underlying appetitive learning: links to drug addiction. Curr Opin Neurobiol 2004; 14: 156-162.
40. Childress AR. What can human brain imaging tell us about vulnerability to addiction and relapse? In: Miller WR, Carroll KM, eds. Rethinking substance abuse: what the science shows and what we should do about it. New York: Guildford Press, 2006:46-60.
41. Kalivas PW, Volkow ND. The neural basis of addiction: A pathology of motivation and choice. Am J Psychiatry 2005; 162: 1403-1413.
42. Schoenbaum G, Roesch MR, Stalnaker TA. Orbitofrontal cortex, decision-making and drug addiction. Trends Neurosci 2006; 29: 116-124.
43. O'Doherty JP. Reward representations and reward-related learning in the human brain: insights from neuroimaging. Curr Opin Neurobiol 2004; 14: 769-776.
44. Musto DF. The American disease: origins of narcotic control. New York: Oxford University Press, 1999.
45. Courtwright DT. Drugs and the making of the modern world. Cambridge, MA: Cambridge University Press, 2001.
46. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey replication. Arch Gen Psychiatry 2005; 62: 593-602. (Pubitemid 40973434)
47. West R. Theories of addiction. Addiction 2001; 96: 3-13.
48. Crabbe JC. Genetic contributions to addiction. Annu Rev Psychol 2002; 53: 435-462.
49. Orford J. Addiction as excessive appetite. Addiction 2 001; 9 6: 1 5- 3 1.
50. Yucel M, Lubman DI, Solowij N, Brewer WJ. Understanding drug addiction: A neuropsychological perspective. Aust N Z J Psychiatry 2007; 41: 957-968.
51. Robins LN, Helzer JE, Davis DH. Narcotic use in southeast Asia and afterward: An interview study of 898 Vietnam returnees. Arch Gen Psychiatry 1975; 32: 955-961.
52. Robins LN, Slobodyan S. Post-Vietnam heroin use and injection by returning US veterans: clues to preventing injection today. Addiction 2003; 98: 1053-1060.
53. Ministry of Health. Drug use in New Zealand: Analysis of the 2003 New Zealand Health Behaviours Survey - Drug Use. Wellington: Ministry of Health, 2007.
54. Australian Institute of Health and Welfare. Statistics on drug use in Australia 2006. Canberra: Australian Institute of Health and Welfare, 2007.
55. Compton WM, Thomas YF, Stinson FS, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 2007; 64: 566-576.
56. Teesson M, Hall W, Lynskey M, Degenhardt L. Alcohol and drug-use disorders in Australia: implications of the National Survey of Mental Health and Wellbeing. Aust N Z J Psychiatry 2000; 34: 206-213.
57. Chambers RA, Taylor JR, Potenza MN. Developmental neurocircutry of motivation in adolescence: A critical period of addiction vulnerability. Am J Psychiatry 2003; 160: 1041-1052.
58. Reyna VF, Farley F. Risk and rationality in adolescent decision making: implications for theory, practice, and public policy. Psychol Sci Public Interest 2006; 7: 1-44.
59. Chisholm JS. Death, hope, and sex: life history theory and the development of reproductive strategies. Curr Anthropol 1993; 34: 1-24.
60. Kaplan HS, Gangestad SW. Life history theory anDevolutionary psychology. In: Buss DM, ed. The handbook of evolutionary psychology. Hoboken, NJ: John Wiley and Sons, 2005:68-95.
61. Wilson M, Daly M. Competitiveness, risk taking, and violence: the young male syndrome. Ethol Sociobiol 1985; 6: 59-73.
62. Mishra S, Lalumière ML. Risk taking, antisocial behaviour, and life histories. In: Duntley JD, Shackelford TK, eds. Evolutionary forensic psychology: Darwinian foundations of crime and law. New York: Oxford University Press, 2008:139-159.
63. Wang XT, Kruger DJ, Wilke A. Life history variables and risktaking propensity. Evol Hum Behav 2009; 30: 77-84.
64. Casey BJ, Getz S, Galvan A. The adolescent brain. Dev Rev 2008; 28: 62-77.
65. Dahl RE. Adolescent brain development: A period of vulnerabilities and opportunities. Ann N Y Acad Sci 2004; 1021: 1-22.
66. Ernst M, Pine DS, Hardin M. Triadic model of the neurobiology of motivated behaviour in adolescence. Psychol Med 2006; 36: 299-312.
67. Steinberg L. Risk taking in adolescence: new perspectives from brain and behavioral science. Curr Dir Psychol Sci 2007; 16: 55-59.
68. Galvan A, Hare TA, Parra CE, et al.. Earlier development of the accumbens relative to orbitofrontal cortex might underlie risktaking behaviour in adolescents. J Neurosci 2006; 26: 6885-6892.
69. Grant JE. Impulse control disorders: A clinician's guide to understanding and treating behavioral addictions. New York: WW Norton, 2008.
70. Holden C. 'Behavioral' addictions: do they exist? Science 2001; 294: 980-982.
71. Potenza MN. S hould addictive disorders include non-substance related conditions? Addiction 2006; 101 (Suppl. 1): 142-151.
72. Reuter J, Raedler T, Rose M, Hand I, Gläscher J, Büchel C. Pathological gambling is linked to reduced activation of the mesolimbic reward system. Nat Neurosci 2005; 8: 147-148.
73. Schmitz JM. The interface between impulse-control disorders and addictions: Are pleasure pathway responses shared neurobiological substrates? Sex Addict Compuls 2005; 12: 149-168.
74. Spinella M. Evolutionary mismatch, neural reward circuits, and pathological gambling. Int J Neurosci 2003; 113: 503-512.
75. Grant JE, Potenza MN, Hollander E, et al.. Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. Am J Psychiatry 2006; 163: 303-312.
76. Kim SW, Grant JE, Adson DE, Shin YC. Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol Psychiatry 2001; 49: 914-921.
77. Klingemann H, Sobell LC. Promoting self-change from addictive behaviors: practical implications for policy, prevention, and treatment. Zurich: Springer, 2007.
78. Ward T, Stewart C. Criminogenic needs and human needs: A theoretical model. Psychol Crime Law 2003; 9: 125-143. (Pubitemid 36614432)
79. Babor TF, Caetano R, Casswell S et al.. Alcohol: noordinary commodity - research and public policy. Oxford: Oxford University Press, 2003.
80. Ghodse H. International drug control into the 21st century. Hampshire , UK: Ashgate Publishing, 2003.